A phase 1/2 study of Ad.p53 DC vaccine with indoximod immunotherapy in metastatic breast cancer

被引：1
|
作者：
Soliman, Hatem H. [1 ]
Minton, Susan E. [1 ]
Ismail-Khan, Roohi [1 ]
Han, Hyo S. [1 ]
Vahanian, Nicholas N. [2 ]
Link, Charles J. [2 ]
Kennedy, Gene [2 ]
Streicher, Howard [3 ]
Sullivan, Daniel [1 ]
Antonia, Scott J. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Temple, TX USA
[2] NewLink Genet Inc, Ames, IA USA
[3] Natl Canc Inst, Bethesda, MD USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.SABCS14-P2-15-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-15-04
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Phase 2 study with pharmacokinetics (PK) analysis of sorafenib and vinorelbine in metastatic breast cancer
    Ferrario, Cristiano
    Miller, Wilson H.
    Charamis, Helen
    Langleben, Adrian
    Oyewole-Eletu, Shola
    Dalfen, Richard
    Patenaude, Francois
    Batist, Gerald
    Panasci, Lawrence C.
    CANCER RESEARCH, 2012, 72
  • [32] Efficacy of Oral Etoposide in Pretreated Metastatic Breast Cancer A Multicenter Phase 2 Study
    Yuan, Peng
    Di, Lijun
    Zhang, Xiaohui
    Yan, Min
    Wan, Donggui
    Li, Li
    Zhang, Yongqiang
    Cai, Jufen
    Dai, Hong
    Zhu, Qi
    Hong, Ruoxi
    Xu, Binghe
    MEDICINE, 2015, 94 (17) : e774
  • [33] Phase I/II study of weekly paclitaxel (P), UFT and leucovorin in patients with metastatic breast cancer
    Chang, AY
    Beith, J
    Yeo, W
    Boyer, M
    Wong, J
    Lim, SE
    Chan, AT
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 59S - 59S
  • [34] Phase 1b/2 study of intratumoral Ad-RTS-hIL-12+veledimex in patients with chemotherapy-responsive locally advanced or metastatic breast cancer
    McArthur, Heather L.
    Page, David B.
    Proverbs-Singh, Tracy Ann
    Solomon, Stephen Barnett
    Hudis, Clifford A.
    Norton, Larry
    Patil, Sujata
    Barrett, John A.
    Lebel, Francois M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [35] Phase 1b/2 study of intratumoral Ad-RTS-hIL-12+veledimex in patients with chemotherapy-responsive locally advanced or metastatic breast cancer
    McArthur, H. L.
    Page, D.
    Proverbs-Singh, T.
    Solomon, S.
    Hudis, C.
    Norton, L.
    Patil, S.
    Barrett, J. A.
    Lebel, F.
    CANCER RESEARCH, 2016, 76
  • [36] p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading
    Guerra, Emanuela
    Cimadamore, Alessia
    Simeone, Pasquale
    Vacca, Giovanna
    Lattanzio, Rossano
    Botti, Gerardo
    Gatta, Valentina
    D'Aurora, Marco
    Simionati, Barbara
    Piantelli, Mauro
    Alberti, Saverio
    BMC CANCER, 2016, 16
  • [37] p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading
    Emanuela Guerra
    Alessia Cimadamore
    Pasquale Simeone
    Giovanna Vacca
    Rossano Lattanzio
    Gerardo Botti
    Valentina Gatta
    Marco D’Aurora
    Barbara Simionati
    Mauro Piantelli
    Saverio Alberti
    BMC Cancer, 16
  • [38] Phase II multicenter study of talazoparib for somatic BRCA1/2 mutant metastatic breast cancer.
    Vidula, Neelima
    Blouch, Erica
    Horick, Nora K.
    Basile, Erin
    Damodaran, Senthil
    Liu, Minetta C.
    Shah, Ami N.
    Moreno-Aspitia, Alvaro
    Rugo, Hope S.
    Ellisen, Leif
    Bardi, Aditya
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [39] Phase II study of a PARP inhibitor in somatic BRCA1/2 mutant metastatic breast cancer (MBC)
    Vidula, Neelima
    Damodaran, Senthil
    Bhave, Manali A.
    Rugo, Hope S.
    Blouch, Erica
    Ruffle-Deignan, Nathan Royce
    Shah, Ami N.
    Cristofanilli, Massimo
    Abramson, Vandana G.
    Sparano, Joseph A.
    Ostrer, Harry
    Horick, Nora K.
    Bardia, Aditya
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [40] Phase I Study of S-1 in Combination with Trastuzumab for HER2-positive Metastatic Breast Cancer
    Nakayama, Takahiro
    Morita, Satoshi
    Takashima, Tsutomu
    Kamigaki, Shunji
    Yoshidome, Katsuhide
    Ito, Toshikazu
    Taguchi, Tetsuya
    Sakamoto, Junichi
    Noguchi, Shinzaburo
    ANTICANCER RESEARCH, 2011, 31 (09) : 3035 - 3039
12345